Identifying insulin-resistant PCOS with LMNA-related lipodystrophy in young women
Official title: Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)
Run by Assistance Publique - Hôpitaux de Paris · NCT07412028 · Data updated 2026-11-12
We’re testing whether women with a genetic insulin resistance and lipodystrophy differ from women with PCOS by age and BMI matching.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 81 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | July 21, 2026 |
| Main results expected | January 2028 |
| Study ends | January 2028 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT07412028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 to 44 with either a known pathogenic LMNA variant causing lipodystrophy or PCOS diagnosed by Rotterdam criteria.
✕Probably not a fit
Participants without the specific LMNA lipodystrophy may not experience a direct benefit beyond contributing to knowledge.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This diagnostic case-control study will compare 25 women with a lipodystrophic syndrome due to LMNA gene variants to 50 PCOS patients who are matched by age and BMI. The study uses genetic analysis, biological testing, and imaging to characterize insulin resistance profiles and related factors. The goal is to understand how the insulin-resistant, lipodystrophic condition presents differently from classic PCOS in women of reproductive age. The design aims to help improve differential diagnosis and future management of rare insulin resistance syndromes presenting with hyperandrogenism.
Why it matters
Potential benefit: If successful, the findings could improve early identification and tailored care for women with rare insulin resistance syndromes presenting as PCOS.
How similar studies have gone: Other studies have explored LMNA-related lipodystrophy and PCOS features, but this exact comparative approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged ≥ 18 years and \< 45 years ; * Discontinuation of estrogen-progestin therapyfor at least 3 months ; * Signed informed consent ; * Social security affiliation. Case (n=25): \- Patient with a lipodystrophic syndrome due to a known pathogenic variant of the LMNA gene. Control (n=50), : \- patient consulting for polycystic ovary syndrome (PCOS according to the Rotterdam criteria) in day hospital matched on age +/-5 years and BMI+/-5 kg/m2. Exclusion Criteria: * \- Severe renal insufficiency (GFR \< 30 ml/min) ; * Hepato-cellular insufficiency (TP \< 50%) ; * Taking corticosteroids or antiretrovirals ; * Menopausal women ; * Taking estrogen-progestin therapy; * Diabetic patients on insulin : type 1 diabetes or pancreatectomised patients * Other known causes of hyperandrogenism (21-hydroxylase block, Cushing's syndrome, ovarian tumor). * Pregnant woman * Breastfeeding woman
Where it's running
-
Service Endocrinologie, Hôpital St Antoine
Paris, France Recruiting
Study contacts
- Principal investigator: Sophie LAMOTHE — Aphp
- Study coordinator: Sophie LAMOTHE, Doctor
- Email: sophie.lamothe@aphp.fr
- Phone: 0149282406
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Precision acupuncture and lifestyle for PCOS
This trial tests whether a precision acupuncture approach combined with a personalized lifestyle plan helps improve insulin resistance in people with PCOS compared with conventional acupuncture and standard lifestyle changes.
-
Orlistat for metabolic and hormonal features in women with PCOS
This trial tests whether adding orlistat to lifestyle advice helps improve metabolic and hormonal aspects in women with PCOS compared to lifestyle advice alone.
-
Physical activity program for women with PCOS and fatty pancreas plus subclinical hypothyroidism
A program of exercise is being tested to see if it helps women with PCOS who also have fatty pancreas and subclinical hypothyroidism, compared to usual care.
-
Glucose monitoring in women with polycystic ovary syndrome
This project will use continuous glucose monitors to see if daily glucose patterns differ among adult women with different PCOS phenotypes.
-
Adding regular exercise to a low‑calorie diet and metformin for women with PCOS and asthma
This study will test whether adding regular treadmill walking to a low‑calorie diet and daily metformin helps women who have both PCOS and asthma.
-
Combining Dlbs 3233 with clomiphene citrate for PCOS
This will test whether adding Dlbs 3233 to clomiphene citrate helps women with PCOS improve insulin resistance (HOMA-IR), follicle maturation, and menstrual cycle regularity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.